Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment. - Wikidata - awgldk - TriplyDB

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

http://www.wikidata.org/entity/Q39352989

about

Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.The challenges and the promise of molecular targeted therapy in malignant gliomas.Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.Current status and future directions of anti-angiogenic therapy for gliomas Overexpression of regulator of G protein signaling 11 promotes cell migration and associates with advanced stages and aggressiveness of lung adenocarcinoma.Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma.Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues.

P2860

Q30725125-20BC4862-9018-42C6-B73E-559ABE902423 Q34394233-0EFB8159-B078-41B1-B18F-1ECC688AF413 Q35214534-0FA974A5-1275-4FDA-899F-453CC26D4E3A Q36107307-20A55348-BA2E-440F-B7EE-F33502AAA713 Q36618235-1D3B8235-7BFD-4804-AD82-457B33E7FA9B Q37327676-56A6AC2D-9A57-4561-A769-729B05762963 Q38778367-6330B6EB-B014-4234-BAAA-1C483D00DEDB Q38962204-46DEC873-5C41-4D6C-893A-034A1BD5CCB4 Q55254148-279F76ED-0DFB-4698-892A-A9D6BCB20AC9

P2860

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

http://www.wikidata.org/entity/Q39352989

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

@en

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

@nl

type

label

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

@en

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

@nl

prefLabel

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

@en

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

@nl

P1433

Q39352989-6850A4CD-8F94-4E08-99A6-3212C3E9C9A4

P1476

Q39352989-F0C7474C-822E-4EAD-A0E7-FF017E05239D

P2093

Q39352989-09D72371-81FA-4C0E-9C2E-1F027C4C27EC

Q39352989-0CA43FD8-3C65-47A5-A741-6C38CD91B7B1

Q39352989-32D9A417-F55A-4EA2-B106-D7D15BB44E25

Q39352989-589E9AC2-E093-427E-AECB-68BD2C181EBB

Q39352989-820858B6-CA82-4CAF-B413-34FC4A56F4DC

Q39352989-878299CB-122E-4F77-A1A4-5A7159101DE2

Q39352989-896DB7AC-61AD-44AB-BEC1-A2E1C42B7E43

Q39352989-AC74EB3A-B707-4644-B29F-A7FAF975F61C

Q39352989-AE8ADB3E-7373-4CBE-B22D-5037D7861D21

Q39352989-B0931C82-4133-4083-8BAA-B2FE7A22815B

P2860

Q39352989-006C96D6-0DC0-4E08-AB7E-354621F8F8CE

Q39352989-0C05FC6C-6A23-4608-9632-F39298E46B45

Q39352989-14C39598-5B7C-40A0-84BC-EC66C013FCD5

Q39352989-1FFD3330-A249-466B-B19E-79C499A79F5B

Q39352989-21832FA6-0DA7-488F-9AB5-B6C1E8DBBB33

Q39352989-24C0A1C7-C6A6-4030-8008-344F98DCCCC5

Q39352989-2BBC38D0-F4CE-4203-AA9A-70BE1C962E55

Q39352989-2D8D07E0-AA69-49CE-A678-C31FDCF7D930

Q39352989-30E50EF3-F2E8-48A2-9307-77B26D1EFF3E

Q39352989-379E23D6-8CA5-41F6-A773-07C7505A4888

P2888

Q39352989-308A0AB5-6CBB-4B7A-B810-C9FF4562A49A

P304

Q39352989-17CA2C1E-C217-406B-8863-E783CF80FA01

P31

Q39352989-15F8575B-85B0-4DB0-9C37-7693189CC9B3

P356

Q39352989-75158EBB-BADD-48CD-AC8E-29582F2241FB

P407

Q39352989-ED948DB8-D360-4DBC-BD2E-5787DB2EB87E

P433

Q39352989-40DB1281-8D06-42CA-9CC6-55EFB4395BAD

P478

Q39352989-6F407042-3F21-417B-8DC2-E99A147507FE

P50

Q39352989-AEBE1165-D168-4B9B-B091-1781C365DD2C

Q39352989-B2467E42-9312-4CBA-B0FC-F177F772A4F6

Q39352989-DF8C4433-88A1-4A3F-B4B8-2243202EC2B6

Q39352989-E1A27521-C6AC-4A78-9770-5A87A5AF7364

P577

Q39352989-7B061BAF-7108-4556-A6DC-E7D43C39804E

P698

Q39352989-DE7E3ED1-C016-4A7A-9191-32892953E1E0

P356

P1433

P1476

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

@en

P2093

A von Deimling

http://www.w3.org/2001/XMLSchema#string

A-L Thiepold

http://www.w3.org/2001/XMLSchema#string

B Berger

http://www.w3.org/2001/XMLSchema#string

J Blaes

http://www.w3.org/2001/XMLSchema#string

J Gronych

http://www.w3.org/2001/XMLSchema#string

L Jestaedt

http://www.w3.org/2001/XMLSchema#string

L M Dittmann

http://www.w3.org/2001/XMLSchema#string

M Jugold

http://www.w3.org/2001/XMLSchema#string

M Kosch

http://www.w3.org/2001/XMLSchema#string

M Weiler

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

The regulator of G protein signaling family

Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin

P2888

P304

1099-1109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2012.137

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Michael Platten

Stephanie E. Combs

Martin Bendszus

P577

2012-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22562250

http://www.w3.org/2001/XMLSchema#string